Malta Looks For European Action On Medicines Price Transparency 02/10/2019 by Elaine Ruth Fletcher Bad Hofgastein, Austria – Malta is working with Italy and 8 other European countries to lay the groundwork for a formal European Union framework in which members could voluntarily share information about medicines prices, in order to advance more coherent pricing policies in regional markets, Malta’s Deputy Prime Minister and Health Minister said on Wednesday. […] Continue reading -> Antimicrobial Resistance Rising Fast In Livestock of Developing World 27/09/2019 by Grace Ren Antimicrobial resistance (AMR) is emerging fast in livestock in the developing world, with northeast India and northern China among the most worrisome “hotspots”, says a first-ever study mapping AMR in low and middle-income countries, published this week in Science. Parts of Turkey, Kenya, Brazil, Egypt, Vietnam and South Africa were also noted as areas of high […] Continue reading -> Ebola On Decline; Vigilance Still Needed, Says WHO Director General 25/09/2019 by Grace Ren NEW YORK CITY – The Ebola outbreak in the Democratic Republic of Congo appears to be finally “on the decline”, World Health Organization Director General Tedros Adhanom Ghebreyesus told reporters Wednesday. Dr Tedros spoke after a meeting at UN Headquarters with new DRC Minister of Health Etembi Longodo and Alex Azar, US Secretary of Health […] Continue reading -> Civil Society Takes Charge On Climate Action As Governments Waver 21/09/2019 by Elaine Ruth Fletcher NEW YORK CITY – Youth leaders from around the world clamored for more action on climate change Saturday at a first-ever United Nation’s Youth Climate Summit – even as the actual government commitments lined up for Monday’s formal meeting with heads of state appeared likely fall far short of making the dramatic changes that scientists […] Continue reading -> New International President Takes Reins of MSF 16/09/2019 by Editorial team Trauma surgeon and veteran field worker, Christos Christou, has taken over the Médecins Sans Frontières (MSF) reins as International President, following his election by the organization’s International General Assembly last June. Christou, former president of the MSF Greece Board of Directors, will be faced with the leadership challenges of an organization that has grown from […] Continue reading -> WHO To Revisit Guidelines On Ebola Survivors’ Care; Study Finds 5-fold Higher Mortality 06/09/2019 by Grace Ren New data revealing that survivors of Guinea’s 2013-16 Ebola outbreak were five times more likely to die within the first year after recovery, as compared to the general population, suggests a need to revisit WHO guidance on Ebola survivors’ monitoring and care, a top WHO official said on Friday. The findings were part of a […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 by Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 by Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Ebola Outbreak Marks 1 Year With Huge Funding Gap, Questions On Vaccine Strategy 01/08/2019 by David Branigan Thursday, 1 August, marked the one-year anniversary of the Ebola outbreak in the Democratic Republic of the Congo (DRC), as daily reports of new infections, including 3 more cases in Goma along DRC’s border with Rwanda, fueled new concerns about regional spread of the deadly disease. Meanwhile, the World Health Organization called on international donors […] Continue reading -> Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 by Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Antimicrobial Resistance Rising Fast In Livestock of Developing World 27/09/2019 by Grace Ren Antimicrobial resistance (AMR) is emerging fast in livestock in the developing world, with northeast India and northern China among the most worrisome “hotspots”, says a first-ever study mapping AMR in low and middle-income countries, published this week in Science. Parts of Turkey, Kenya, Brazil, Egypt, Vietnam and South Africa were also noted as areas of high […] Continue reading -> Ebola On Decline; Vigilance Still Needed, Says WHO Director General 25/09/2019 by Grace Ren NEW YORK CITY – The Ebola outbreak in the Democratic Republic of Congo appears to be finally “on the decline”, World Health Organization Director General Tedros Adhanom Ghebreyesus told reporters Wednesday. Dr Tedros spoke after a meeting at UN Headquarters with new DRC Minister of Health Etembi Longodo and Alex Azar, US Secretary of Health […] Continue reading -> Civil Society Takes Charge On Climate Action As Governments Waver 21/09/2019 by Elaine Ruth Fletcher NEW YORK CITY – Youth leaders from around the world clamored for more action on climate change Saturday at a first-ever United Nation’s Youth Climate Summit – even as the actual government commitments lined up for Monday’s formal meeting with heads of state appeared likely fall far short of making the dramatic changes that scientists […] Continue reading -> New International President Takes Reins of MSF 16/09/2019 by Editorial team Trauma surgeon and veteran field worker, Christos Christou, has taken over the Médecins Sans Frontières (MSF) reins as International President, following his election by the organization’s International General Assembly last June. Christou, former president of the MSF Greece Board of Directors, will be faced with the leadership challenges of an organization that has grown from […] Continue reading -> WHO To Revisit Guidelines On Ebola Survivors’ Care; Study Finds 5-fold Higher Mortality 06/09/2019 by Grace Ren New data revealing that survivors of Guinea’s 2013-16 Ebola outbreak were five times more likely to die within the first year after recovery, as compared to the general population, suggests a need to revisit WHO guidance on Ebola survivors’ monitoring and care, a top WHO official said on Friday. The findings were part of a […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 by Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 by Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Ebola Outbreak Marks 1 Year With Huge Funding Gap, Questions On Vaccine Strategy 01/08/2019 by David Branigan Thursday, 1 August, marked the one-year anniversary of the Ebola outbreak in the Democratic Republic of the Congo (DRC), as daily reports of new infections, including 3 more cases in Goma along DRC’s border with Rwanda, fueled new concerns about regional spread of the deadly disease. Meanwhile, the World Health Organization called on international donors […] Continue reading -> Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 by Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Ebola On Decline; Vigilance Still Needed, Says WHO Director General 25/09/2019 by Grace Ren NEW YORK CITY – The Ebola outbreak in the Democratic Republic of Congo appears to be finally “on the decline”, World Health Organization Director General Tedros Adhanom Ghebreyesus told reporters Wednesday. Dr Tedros spoke after a meeting at UN Headquarters with new DRC Minister of Health Etembi Longodo and Alex Azar, US Secretary of Health […] Continue reading -> Civil Society Takes Charge On Climate Action As Governments Waver 21/09/2019 by Elaine Ruth Fletcher NEW YORK CITY – Youth leaders from around the world clamored for more action on climate change Saturday at a first-ever United Nation’s Youth Climate Summit – even as the actual government commitments lined up for Monday’s formal meeting with heads of state appeared likely fall far short of making the dramatic changes that scientists […] Continue reading -> New International President Takes Reins of MSF 16/09/2019 by Editorial team Trauma surgeon and veteran field worker, Christos Christou, has taken over the Médecins Sans Frontières (MSF) reins as International President, following his election by the organization’s International General Assembly last June. Christou, former president of the MSF Greece Board of Directors, will be faced with the leadership challenges of an organization that has grown from […] Continue reading -> WHO To Revisit Guidelines On Ebola Survivors’ Care; Study Finds 5-fold Higher Mortality 06/09/2019 by Grace Ren New data revealing that survivors of Guinea’s 2013-16 Ebola outbreak were five times more likely to die within the first year after recovery, as compared to the general population, suggests a need to revisit WHO guidance on Ebola survivors’ monitoring and care, a top WHO official said on Friday. The findings were part of a […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 by Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 by Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Ebola Outbreak Marks 1 Year With Huge Funding Gap, Questions On Vaccine Strategy 01/08/2019 by David Branigan Thursday, 1 August, marked the one-year anniversary of the Ebola outbreak in the Democratic Republic of the Congo (DRC), as daily reports of new infections, including 3 more cases in Goma along DRC’s border with Rwanda, fueled new concerns about regional spread of the deadly disease. Meanwhile, the World Health Organization called on international donors […] Continue reading -> Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 by Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Civil Society Takes Charge On Climate Action As Governments Waver 21/09/2019 by Elaine Ruth Fletcher NEW YORK CITY – Youth leaders from around the world clamored for more action on climate change Saturday at a first-ever United Nation’s Youth Climate Summit – even as the actual government commitments lined up for Monday’s formal meeting with heads of state appeared likely fall far short of making the dramatic changes that scientists […] Continue reading -> New International President Takes Reins of MSF 16/09/2019 by Editorial team Trauma surgeon and veteran field worker, Christos Christou, has taken over the Médecins Sans Frontières (MSF) reins as International President, following his election by the organization’s International General Assembly last June. Christou, former president of the MSF Greece Board of Directors, will be faced with the leadership challenges of an organization that has grown from […] Continue reading -> WHO To Revisit Guidelines On Ebola Survivors’ Care; Study Finds 5-fold Higher Mortality 06/09/2019 by Grace Ren New data revealing that survivors of Guinea’s 2013-16 Ebola outbreak were five times more likely to die within the first year after recovery, as compared to the general population, suggests a need to revisit WHO guidance on Ebola survivors’ monitoring and care, a top WHO official said on Friday. The findings were part of a […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 by Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 by Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Ebola Outbreak Marks 1 Year With Huge Funding Gap, Questions On Vaccine Strategy 01/08/2019 by David Branigan Thursday, 1 August, marked the one-year anniversary of the Ebola outbreak in the Democratic Republic of the Congo (DRC), as daily reports of new infections, including 3 more cases in Goma along DRC’s border with Rwanda, fueled new concerns about regional spread of the deadly disease. Meanwhile, the World Health Organization called on international donors […] Continue reading -> Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 by Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New International President Takes Reins of MSF 16/09/2019 by Editorial team Trauma surgeon and veteran field worker, Christos Christou, has taken over the Médecins Sans Frontières (MSF) reins as International President, following his election by the organization’s International General Assembly last June. Christou, former president of the MSF Greece Board of Directors, will be faced with the leadership challenges of an organization that has grown from […] Continue reading -> WHO To Revisit Guidelines On Ebola Survivors’ Care; Study Finds 5-fold Higher Mortality 06/09/2019 by Grace Ren New data revealing that survivors of Guinea’s 2013-16 Ebola outbreak were five times more likely to die within the first year after recovery, as compared to the general population, suggests a need to revisit WHO guidance on Ebola survivors’ monitoring and care, a top WHO official said on Friday. The findings were part of a […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 by Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 by Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Ebola Outbreak Marks 1 Year With Huge Funding Gap, Questions On Vaccine Strategy 01/08/2019 by David Branigan Thursday, 1 August, marked the one-year anniversary of the Ebola outbreak in the Democratic Republic of the Congo (DRC), as daily reports of new infections, including 3 more cases in Goma along DRC’s border with Rwanda, fueled new concerns about regional spread of the deadly disease. Meanwhile, the World Health Organization called on international donors […] Continue reading -> Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 by Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO To Revisit Guidelines On Ebola Survivors’ Care; Study Finds 5-fold Higher Mortality 06/09/2019 by Grace Ren New data revealing that survivors of Guinea’s 2013-16 Ebola outbreak were five times more likely to die within the first year after recovery, as compared to the general population, suggests a need to revisit WHO guidance on Ebola survivors’ monitoring and care, a top WHO official said on Friday. The findings were part of a […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 by Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 by Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Ebola Outbreak Marks 1 Year With Huge Funding Gap, Questions On Vaccine Strategy 01/08/2019 by David Branigan Thursday, 1 August, marked the one-year anniversary of the Ebola outbreak in the Democratic Republic of the Congo (DRC), as daily reports of new infections, including 3 more cases in Goma along DRC’s border with Rwanda, fueled new concerns about regional spread of the deadly disease. Meanwhile, the World Health Organization called on international donors […] Continue reading -> Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 by Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 by Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 by Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Ebola Outbreak Marks 1 Year With Huge Funding Gap, Questions On Vaccine Strategy 01/08/2019 by David Branigan Thursday, 1 August, marked the one-year anniversary of the Ebola outbreak in the Democratic Republic of the Congo (DRC), as daily reports of new infections, including 3 more cases in Goma along DRC’s border with Rwanda, fueled new concerns about regional spread of the deadly disease. Meanwhile, the World Health Organization called on international donors […] Continue reading -> Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 by Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 by Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Ebola Outbreak Marks 1 Year With Huge Funding Gap, Questions On Vaccine Strategy 01/08/2019 by David Branigan Thursday, 1 August, marked the one-year anniversary of the Ebola outbreak in the Democratic Republic of the Congo (DRC), as daily reports of new infections, including 3 more cases in Goma along DRC’s border with Rwanda, fueled new concerns about regional spread of the deadly disease. Meanwhile, the World Health Organization called on international donors […] Continue reading -> Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 by Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Ebola Outbreak Marks 1 Year With Huge Funding Gap, Questions On Vaccine Strategy 01/08/2019 by David Branigan Thursday, 1 August, marked the one-year anniversary of the Ebola outbreak in the Democratic Republic of the Congo (DRC), as daily reports of new infections, including 3 more cases in Goma along DRC’s border with Rwanda, fueled new concerns about regional spread of the deadly disease. Meanwhile, the World Health Organization called on international donors […] Continue reading -> Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 by Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 by Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Posts navigation Older postsNewer posts